TLRs, particularly TLR2 and TLR4, are expressed at higher levels in patients with MS and in rodents with experimental autoimmune encephalomyelitis (EAE), an animal model of MS, indicating their role in the pathogenesis of MS (10-12). Here, TLR2 is linked to myeloid sarcoma.